Chronos Archive seal
The Human Record

Higuchi Ichiyō

Case HR-NI029 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
May 2, 1872 – November 23, 1896
Synthetic DOB
2002-05-02
Index visit
2026-04-14 at age 23
Synthetic MRN
HR-NI029-SYN

Teaching objective: Recognize and treat pulmonary tuberculosis in a 23-year-old writer in Tokyo with a low income, inside Japan's public health system: seven weeks of cough, fevers, night sweats and weight loss resolved into a diagnosis by chest X-ray, three sputum specimens for acid-fast smear, Xpert MTB/RIF Ultra with rifampin resistance, liquid culture and drug susceptibility testing; HIV, hepatitis and pregnancy testing, baseline liver tests, vision testing before ethambutol, and diabetes screening; airborne precautions and immediate notification to the public health center under the Infectious Diseases Control Law; outpatient care with public funding for a smear-negative patient; the choice of the standard six-month regimen (isoniazid, rifampin, pyrazinamide and ethambutol for eight weeks, then isoniazid and rifampin for eighteen weeks) because her weight is below the 40 kg needed for the four-month rifapentine-moxifloxacin regimen; daily video-observed therapy with pyridoxine; monitoring for liver injury and optic neuropathy; a contact investigation of her household led by the public health center; treatment of moderate malnutrition and help with income; contraception counseling for rifampin interactions; and a paced plan that lets her keep writing. The modern episode is a teaching case, not a claim about her real illness or care.

Historical timeline

DateEventClaims
May 2, 1872Born in Tokyo (Meiji 5, 3rd month, 25th day, in the lunisolar calendar).CLM-0001, CLM-0002
1886Begins the study of classical poetry at the Haginoya.CLM-0003
summer 1889Her father dies; she becomes head of the household.CLM-0004
1891Becomes a pupil of Nakarai Tōsui and begins to write fiction.CLM-0005
July 1893Opens a small shop in Shitaya Ryūsenji-chō beside the Yoshiwara; it closes in April 1894.CLM-0006
May 1894Moves to Hongō Maruyama-Fukuyama-chō; her major works follow.CLM-0007, CLM-0008
early 1896Her health declines rapidly.CLM-0010
November 23, 1896Dies of tuberculosis at home in Hongō, at 24.CLM-0011, CLM-0009
November 1, 2004Her portrait appears on the new 5,000-yen note.CLM-0012

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Higuchi Ichiyō, whose given name was Natsu (also written Natsuko), was born in Tokyo on the 25th day of the 3rd month of Meiji 5 in the Japanese lunisolar calendar, which is 2 May 1872 in the Gregorian calendar, in official housing within the grounds of the Tokyo prefectural office in Uchisaiwai-chō (now in Chiyoda). confirmed Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports
樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus supports
Higuchi Ichiyō (Shapers of Japanese History) supports
HISTMED Master Roster v3 context
D Japan replaced its lunisolar calendar with the Gregorian calendar at the end of Meiji 5: the 3rd day of the 12th month of Meiji 5 became 1 January 1873 (Meiji 6). Dates before then, including her birth, were recorded in the old calendar.
Explains why her birth date is given in two calendars.
confirmed Calendar History 2 (The Japanese Calendar) supports
D From 1886 she studied classical poetry (waka) at the Haginoya academy of Nakajima Utako. confirmed Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports
樋口一葉 (Higuchi Ichiyō), 文京ゆかりの文人 supports
D Her father died of illness in the summer of 1889, when she was 17, leaving debts from a failed business; she became head of the household and took on the support of her mother and younger sister, who did washing and needlework, and the family lived in poverty.
History only; her mother and sister are given no role in the modern episode.
confirmed Higuchi Ichiyō (Shapers of Japanese History) supports
Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports
Ichiyo Memorial Museum supports
樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus supports
D In 1891 she became a pupil of the novelist Nakarai Tōsui and began to write fiction, choosing to earn her living by writing at a time when this was very hard for a woman; her story Umoregi (1892) brought her into the literary world.
Anchors her modern occupation as a writer.
confirmed Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports
Ichiyo Memorial Museum supports
D From July 1893 to April 1894 she ran a small shop selling household goods and cheap sweets in Shitaya Ryūsenji-chō, beside the Yoshiwara pleasure quarter (now in Taitō); the shop closed after about ten months, and her life there became material for Takekurabe.
History only.
confirmed 樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus supports
Higuchi Ichiyō (Shapers of Japanese History) supports
Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports
Ichiyo Memorial Museum supports
D In May 1894 she moved to Hongō Maruyama-Fukuyama-chō (now Nishikata, Bunkyō).
Anchors the place of the index date.
confirmed 樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus supports
樋口一葉 (Higuchi Ichiyō), 文京ゆかりの文人 supports
D At Maruyama-Fukuyama-chō she wrote the works that made her name, among them Ōtsugomori (1894), Nigorie (1895), Takekurabe (1895 to 1896) and Jūsan'ya; Nippon.com calls the period 'the miraculous 14 months', and the Nipponica encyclopedia calls the time up to January 1896 'the miraculous year'.
Anchors the modern episode's attention to her writing; the two sources measure the period differently.
confirmed Higuchi Ichiyō (Shapers of Japanese History) supports
樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus supports
樋口一葉 (Higuchi Ichiyō), 文京ゆかりの文人 supports
Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports
D She died in poverty.
Anchors the low income in the modern social history.
confirmed Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports
D From the beginning of 1896 her health declined rapidly.
The anchor for the index date and the presenting illness.
confirmed 樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus supports
D She died of tuberculosis on 23 November 1896 at her home in Hongō, at the age of 24. The National Diet Library gives the cause as lung tuberculosis; the Nipponica encyclopedia gives miliary tuberculosis.
After the index date. Tuberculosis is documented; the sources differ on its form (pulmonary or miliary), so the modern pulmonary diagnosis is linked to the documented disease, not to either form.
confirmed Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports
樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus supports
樋口一葉 (Higuchi Ichiyō), 文京ゆかりの文人 supports
Higuchi Ichiyō (Shapers of Japanese History) supports
Ichiyo Memorial Museum supports
D Her portrait appears on the Bank of Japan 5,000-yen note first issued on 1 November 2004, whose back shows Ogata Kōrin's painting of irises; a new 5,000-yen note with a different portrait was first issued on 3 July 2024.
History only.
confirmed Bank of Japan Notes and Coins Currently Issued supports
Higuchi Ichiyō (Shapers of Japanese History) supports
Ichiyo Memorial Museum supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Cough for about seven weeks with evening fevers, night sweats, poor appetite and weight loss of about 4 kg (about 10 percent) in a woman of 23; chest X-ray with patchy right upper lobe opacities and no cavity; suspected pulmonary tuberculosis; airborne precautions and three sputum specimens for acid-fast smear, nucleic acid amplification and culture resolved confirmed active CLM-0010
S Pulmonary tuberculosis of the right upper lobe, sputum smear-negative, confirmed by Xpert MTB/RIF Ultra (Mycobacterium tuberculosis detected, low; rifampin resistance not detected) resolved confirmed both_with_link CLM-0010, CLM-0011
S Moderate protein-calorie malnutrition: BMI 17.6, about 10 percent weight loss in two months, and albumin 3.3 g/dL resolved confirmed active CLM-0004, CLM-0009
S Low and irregular income from writing, with a household to support; costs of care are a barrier active confirmed active CLM-0004, CLM-0009
S Acute uncomplicated cystitis, treated with nitrofurantoin rather than a fluoroquinolone during tuberculosis treatment; resolved resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-04-14 Hemoglobin [Mass/volume] in Blood 11.4 g/dL (low)
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 2026-04-14 Leukocytes [#/volume] in Blood by Automated count 8.6 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-04-14 Platelets [#/volume] in Blood by Automated count 452 10*3/uL (high)
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-04-14 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 12 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 2026-04-14 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 19 U/L
Reference 10-35 U/L
http://loinc.org · 1920-8
S 2026-04-14 Bilirubin.total [Mass/volume] in Serum or Plasma 0.4 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 2026-04-14 Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 74 U/L
Reference 35-104 U/L
http://loinc.org · 6768-6
S 2026-04-14 Albumin [Mass/volume] in Serum or Plasma 3.3 g/dL (low)
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 2026-04-14 Creatinine [Mass/volume] in Serum or Plasma 0.56 mg/dL
Reference 0.5-1 mg/dL
http://loinc.org · 2160-0
S 2026-04-14 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 131 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-04-14 Glucose [Mass/volume] in Serum or Plasma 82 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-04-14 Hemoglobin A1c/Hemoglobin.total in Blood 5.1%
Reference Below 5.7% is normal; 6.5% or more is diabetes
http://loinc.org · 4548-4
S 2026-04-14 Visual acuity uncorrected Right eye by ETDRS eye chart 85
Reference >=80
http://loinc.org · 79878-5
S 2026-04-14 Visual acuity uncorrected Left eye by ETDRS eye chart 85
Reference >=80
http://loinc.org · 79879-3
S 2026-04-14 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 8 http://loinc.org · 44261-6
S 2026-04-14 Total score [AUDIT-C] 0 http://loinc.org · 75626-2
S 2026-05-01 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 2026-05-01 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 U/L
Reference 10-35 U/L
http://loinc.org · 1920-8
S 2026-05-01 Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 2026-05-01 Visual acuity uncorrected Right eye by ETDRS eye chart 85
Reference >=80
http://loinc.org · 79878-5
S 2026-05-01 Visual acuity uncorrected Left eye by ETDRS eye chart 84
Reference >=80
http://loinc.org · 79879-3
S 2026-06-12 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 26 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 2026-06-12 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 25 U/L
Reference 10-35 U/L
http://loinc.org · 1920-8
S 2026-06-12 Bilirubin.total [Mass/volume] in Serum or Plasma 0.5 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 2026-06-12 Albumin [Mass/volume] in Serum or Plasma 3.8 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 2026-06-12 Hemoglobin [Mass/volume] in Blood 12.4 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 2026-06-12 Visual acuity uncorrected Right eye by ETDRS eye chart 85
Reference >=80
http://loinc.org · 79878-5
S 2026-06-12 Visual acuity uncorrected Left eye by ETDRS eye chart 85
Reference >=80
http://loinc.org · 79879-3
S 2026-06-12 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 http://loinc.org · 44261-6
S 2026-10-20 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 18 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 2026-10-20 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 20 U/L
Reference 10-35 U/L
http://loinc.org · 1920-8
S 2026-10-20 Albumin [Mass/volume] in Serum or Plasma 4.2 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 2026-10-20 Hemoglobin [Mass/volume] in Blood 13.2 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 2026-10-20 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 http://loinc.org · 44261-6
S 2026-08-24 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 2026-08-24 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 4 http://loinc.org · 70274-6
S 2026-08-24 Total score [AUDIT-C] 0 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-04-14Body height148 cm8302-2S
2026-04-14Body weight38.5 kg29463-7S
2026-04-14Body mass index (BMI) [Ratio]17.6 kg/m239156-5S
2026-04-14Systolic blood pressure98 mm[Hg]8480-6S
2026-04-14Diastolic blood pressure62 mm[Hg]8462-4S
2026-04-14Heart rate104 /min8867-4S
2026-04-14Respiratory rate20 /min9279-1S
2026-04-14Body temperature37.8 Cel8310-5S
2026-04-14Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S
2026-04-17Body height148 cm8302-2S
2026-04-17Body weight38.4 kg29463-7S
2026-04-17Body mass index (BMI) [Ratio]17.5 kg/m239156-5S
2026-04-17Systolic blood pressure96 mm[Hg]8480-6S
2026-04-17Diastolic blood pressure60 mm[Hg]8462-4S
2026-04-17Heart rate100 /min8867-4S
2026-04-17Respiratory rate20 /min9279-1S
2026-04-17Body temperature37.6 Cel8310-5S
2026-04-17Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S
2026-05-01Body height148 cm8302-2S
2026-05-01Body weight39.2 kg29463-7S
2026-05-01Body mass index (BMI) [Ratio]17.9 kg/m239156-5S
2026-05-01Systolic blood pressure100 mm[Hg]8480-6S
2026-05-01Diastolic blood pressure62 mm[Hg]8462-4S
2026-05-01Heart rate90 /min8867-4S
2026-05-01Respiratory rate18 /min9279-1S
2026-05-01Body temperature37.1 Cel8310-5S
2026-05-01Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
2026-06-12Body height148 cm8302-2S
2026-06-12Body weight41 kg29463-7S
2026-06-12Body mass index (BMI) [Ratio]18.7 kg/m239156-5S
2026-06-12Systolic blood pressure102 mm[Hg]8480-6S
2026-06-12Diastolic blood pressure64 mm[Hg]8462-4S
2026-06-12Heart rate80 /min8867-4S
2026-06-12Respiratory rate16 /min9279-1S
2026-06-12Body temperature36.8 Cel8310-5S
2026-06-12Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-10-20Body height148 cm8302-2S
2026-10-20Body weight44 kg29463-7S
2026-10-20Body mass index (BMI) [Ratio]20.1 kg/m239156-5S
2026-10-20Systolic blood pressure106 mm[Hg]8480-6S
2026-10-20Diastolic blood pressure68 mm[Hg]8462-4S
2026-10-20Heart rate72 /min8867-4S
2026-10-20Respiratory rate14 /min9279-1S
2026-10-20Body temperature36.5 Cel8310-5S
2026-10-20Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-07-20Body height148 cm8302-2S
2026-07-20Body weight42 kg29463-7S
2026-07-20Body mass index (BMI) [Ratio]19.2 kg/m239156-5S
2026-07-20Systolic blood pressure104 mm[Hg]8480-6S
2026-07-20Diastolic blood pressure66 mm[Hg]8462-4S
2026-07-20Heart rate84 /min8867-4S
2026-07-20Respiratory rate16 /min9279-1S
2026-07-20Body temperature37 Cel8310-5S
2026-07-20Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-08-24Body height148 cm8302-2S
2026-08-24Body weight42.6 kg29463-7S
2026-08-24Body mass index (BMI) [Ratio]19.4 kg/m239156-5S
2026-08-24Systolic blood pressure104 mm[Hg]8480-6S
2026-08-24Diastolic blood pressure66 mm[Hg]8462-4S
2026-08-24Heart rate76 /min8867-4S
2026-08-24Respiratory rate14 /min9279-1S
2026-08-24Body temperature36.6 Cel8310-5S
2026-08-24Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
Complete 182 daily doses within about six and a half months by video-observed therapy2026-10-20completedAll 182 doses completed in 26 weeks: 56 in the intensive phase and 126 in the continuation phase, none missed
Sputum culture negative at two months2026-10-20completedThe cultures taken at two weeks and at two months both showed no growth after six weeks
Weight at least 44 kg (BMI about 20) by the end of treatment2026-10-20completed44.0 kg at the end of treatment, from 38.5 kg at intake
Keep writing on a paced schedule without losing income during treatment2026-10-20completedPublic funding covered most treatment costs; she kept writing about two hours a day and finished new work
No drug-induced liver injury or loss of vision during treatment2026-10-20completedLiver tests normal throughout; visual acuity unchanged

Interventions

InterventionStatusGuideline
Diagnosis and safety: chest X-ray; three sputum specimens at least eight hours apart, one early in the morning, for acid-fast smear, Xpert MTB/RIF Ultra, liquid and solid culture and drug susceptibility testing; HIV, hepatitis B and hepatitis C tests and a pregnancy test; blood count, liver and kidney tests, glucose and hemoglobin A1c; visual acuity and color vision before ethambutolcompletedGL-ATS-TBDX-2017, GL-ATS-TB-2016, GL-WHO-TB-2022
Infectious diseases consultation at the results visit to confirm the diagnosis, choose between the six-month and four-month regimens, set the doses for her weight, and plan monitoring and infection controlcompletedGL-ATS-TB-2016, GL-ATS-TB-2025, GL-CDC-4MO-2022
Infection control and public health: airborne precautions in the clinic; at home, no visitors, a surgical mask in shared rooms, windows open, and sleeping in her own room until the public health center confirms she is no longer infectious; report of suspected tuberculosis to the public health center the same day and notification at once on diagnosis; a contact investigation of her household and other close contacts led by the public health centercompletedGL-MHLW-TB-NOTIFY, GL-CDC-CONTACT-2005, GL-ATS-TB-2016
Nutrition, income and writing: two dietitian visits in the first month, three meals and two energy-dense snacks a day with two oral nutrition supplement drinks, and weight at every visit; a medical social worker to apply for public funding of tuberculosis treatment and to review other help with costs; a paced writing plan of short sessions in daylight with rest; PHQ-9 at intake, at two months and at the end of treatmentcompletedGL-ASPEN-MALN-2012, GL-JP-TB-FUNDING, GL-USPSTF-DEP-2023
Treatment: isoniazid 200 mg, rifampin 450 mg, pyrazinamide 1000 mg and ethambutol 600 mg daily for eight weeks, then isoniazid and rifampin daily for eighteen weeks, with pyridoxine 50 mg, by daily video-observed therapy with the public health center; ethambutol stopped once the isolate is susceptible to isoniazid and rifampin; liver tests at two weeks and monthly in the intensive phase because of her low weight and albumin; visual acuity and color vision monthly while on ethambutol; sputum smear and culture at two weeks and two months; chest X-ray at the end of treatmentcompletedGL-ATS-TB-2016, GL-ATS-TB-2025, GL-WHO-TB-2022, GL-ATS-HEPATOTOX-2006
Acute cystitis: nitrofurantoin 100 mg twice daily for five days with urine culture; no fluoroquinolone, because these drugs are kept for drug-resistant tuberculosis and can blur the picture of tuberculosis; continue every tuberculosis dose; plenty of fluids; return for fever, flank pain, vomiting or symptoms that are not better in two dayscompletedGL-IDSA-UTI-2010, GL-ATS-TB-2016
Prevention: cervical cytology now and every three years; Tdap; hepatitis B vaccine in two doses and HPV vaccine in three doses; influenza vaccine in the autumn; folic acid 0.4 mg daily advised; contraception counseling that rifampin makes hormonal pills, patches, rings and implants unreliable, with a copper IUD, injectable progestin or condoms as reliable choices if she needs contraception during treatmentcompletedGL-USPSTF-CERV-2018, GL-CDC-IMZ-2026, GL-CDC-SPR-2024, GL-USPSTF-FOLIC-2023

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo National Diet Library, Japan biography
SRC-0002 樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus Kotobank (Asahi Shimbun), carrying Shogakukan, Heibonsha and Kodansha reference works scholarly
SRC-0003 Higuchi Ichiyō (Shapers of Japanese History) Nippon.com (Nippon Communications Foundation) biography
SRC-0004 Ichiyo Memorial Museum Taito City Culture Foundation (Ichiyō Memorial Museum, Taitō, Tokyo) biography
SRC-0005 Bank of Japan Notes and Coins Currently Issued Bank of Japan other
SRC-0006 Calendar History 2 (The Japanese Calendar) National Diet Library, Japan scholarly
SRC-0007 樋口一葉 (Higuchi Ichiyō), 文京ゆかりの文人 Bunkyō City, Tokyo biography
SRC-0009 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check outpatient care for smear-negative, Xpert-positive disease in Japan, the six-month regimen chosen because her weight is below 40 kg, the weight-based doses, liver monitoring in a malnourished woman, and the recorded gap in month-one monitoring.
provenance reviewnot_startedNational Diet Library portrait biography and calendar page, Kotobank encyclopedia entries (Nipponica and others), Nippon.com, the Ichiyō Memorial Museum page, the Bunkyō City biography, and the Bank of Japan banknote page logged. Danly's biography was not read. The form of her fatal tuberculosis differs between sources (pulmonary or miliary).
safe messaging reviewnot_startedNo psychiatric claim is made; PHQ-9 at most 8 with item 9 scored 0, so no safety assessment is required. Her mother and sister appear only in documented history; the household contact investigation names no one and records no result. Her death is recorded in one sentence.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.